Cargando…
A seven-miRNA expression-based prognostic signature and its corresponding potential competing endogenous RNA network in early pancreatic cancer
The present study aimed to establish a microRNA (miRNA/miR) signature to predict the prognosis of patients with pancreatic cancer (PC) at the early stage and to investigate the involvement of competing endogenous RNAs (ceRNAs) in PC. Using mature miRNA expression profiles from The Cancer Genome Atla...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676175/ https://www.ncbi.nlm.nih.gov/pubmed/31410115 http://dx.doi.org/10.3892/etm.2019.7728 |
_version_ | 1783440725426307072 |
---|---|
author | Bai, Xue Lu, Donglan Lin, Yan Lv, Yufeng He, Liusheng |
author_facet | Bai, Xue Lu, Donglan Lin, Yan Lv, Yufeng He, Liusheng |
author_sort | Bai, Xue |
collection | PubMed |
description | The present study aimed to establish a microRNA (miRNA/miR) signature to predict the prognosis of patients with pancreatic cancer (PC) at the early stage and to investigate the involvement of competing endogenous RNAs (ceRNAs) in PC. Using mature miRNA expression profiles from The Cancer Genome Atlas, differentially expressed miRNAs in tissues derived from patients exhibiting early PC and tissues from healthy individuals were compared. The least absolute shrinkage and selection operator regression method was used to construct a miRNA-based signature for predicting prognosis. The miRNet tool, gene set enrichment analysis (GSEA) and the LncRNADisease database were utilized to explore the mechanistic involvement of ceRNAs. A total of seven downregulated miRNAs in PC (miR-424-5p, miR-139-5p, miR-5586-5p, miR-126-3p, miR-3613-5p, miR-454-3p and miR-1271-5p) were selected to generate a signature. Based on this seven-miRNA signature, it was possible to stratify patients with PC into low- and high-risk groups. The overall survival of the low-risk group was significantly longer than that of the high-risk group (P<0.001). The seven-miRNA signature was able to predict the 2-year-survival rate of patients with early PC with an area under the curve of 0.750. Furthermore, as opposed to routine clinicopathological features, this seven-miRNA signature was an independent prognostic factor according to multivariate Cox regression analysis. GSEA indicated that the extracellular matrix receptor interaction pathway and the transforming growth factor-β signaling pathway were enriched in the high-risk group. A ceRNA network of the seven-miR signature was constructed. In conclusion, the present study provided a seven-miRNA signature, according to which patients with early PC may be divided into high- and low-risk groups. The ceRNA network of the prognostic signature was preliminarily explored. |
format | Online Article Text |
id | pubmed-6676175 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-66761752019-08-13 A seven-miRNA expression-based prognostic signature and its corresponding potential competing endogenous RNA network in early pancreatic cancer Bai, Xue Lu, Donglan Lin, Yan Lv, Yufeng He, Liusheng Exp Ther Med Articles The present study aimed to establish a microRNA (miRNA/miR) signature to predict the prognosis of patients with pancreatic cancer (PC) at the early stage and to investigate the involvement of competing endogenous RNAs (ceRNAs) in PC. Using mature miRNA expression profiles from The Cancer Genome Atlas, differentially expressed miRNAs in tissues derived from patients exhibiting early PC and tissues from healthy individuals were compared. The least absolute shrinkage and selection operator regression method was used to construct a miRNA-based signature for predicting prognosis. The miRNet tool, gene set enrichment analysis (GSEA) and the LncRNADisease database were utilized to explore the mechanistic involvement of ceRNAs. A total of seven downregulated miRNAs in PC (miR-424-5p, miR-139-5p, miR-5586-5p, miR-126-3p, miR-3613-5p, miR-454-3p and miR-1271-5p) were selected to generate a signature. Based on this seven-miRNA signature, it was possible to stratify patients with PC into low- and high-risk groups. The overall survival of the low-risk group was significantly longer than that of the high-risk group (P<0.001). The seven-miRNA signature was able to predict the 2-year-survival rate of patients with early PC with an area under the curve of 0.750. Furthermore, as opposed to routine clinicopathological features, this seven-miRNA signature was an independent prognostic factor according to multivariate Cox regression analysis. GSEA indicated that the extracellular matrix receptor interaction pathway and the transforming growth factor-β signaling pathway were enriched in the high-risk group. A ceRNA network of the seven-miR signature was constructed. In conclusion, the present study provided a seven-miRNA signature, according to which patients with early PC may be divided into high- and low-risk groups. The ceRNA network of the prognostic signature was preliminarily explored. D.A. Spandidos 2019-09 2019-07-03 /pmc/articles/PMC6676175/ /pubmed/31410115 http://dx.doi.org/10.3892/etm.2019.7728 Text en Copyright: © Bai et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Bai, Xue Lu, Donglan Lin, Yan Lv, Yufeng He, Liusheng A seven-miRNA expression-based prognostic signature and its corresponding potential competing endogenous RNA network in early pancreatic cancer |
title | A seven-miRNA expression-based prognostic signature and its corresponding potential competing endogenous RNA network in early pancreatic cancer |
title_full | A seven-miRNA expression-based prognostic signature and its corresponding potential competing endogenous RNA network in early pancreatic cancer |
title_fullStr | A seven-miRNA expression-based prognostic signature and its corresponding potential competing endogenous RNA network in early pancreatic cancer |
title_full_unstemmed | A seven-miRNA expression-based prognostic signature and its corresponding potential competing endogenous RNA network in early pancreatic cancer |
title_short | A seven-miRNA expression-based prognostic signature and its corresponding potential competing endogenous RNA network in early pancreatic cancer |
title_sort | seven-mirna expression-based prognostic signature and its corresponding potential competing endogenous rna network in early pancreatic cancer |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676175/ https://www.ncbi.nlm.nih.gov/pubmed/31410115 http://dx.doi.org/10.3892/etm.2019.7728 |
work_keys_str_mv | AT baixue asevenmirnaexpressionbasedprognosticsignatureanditscorrespondingpotentialcompetingendogenousrnanetworkinearlypancreaticcancer AT ludonglan asevenmirnaexpressionbasedprognosticsignatureanditscorrespondingpotentialcompetingendogenousrnanetworkinearlypancreaticcancer AT linyan asevenmirnaexpressionbasedprognosticsignatureanditscorrespondingpotentialcompetingendogenousrnanetworkinearlypancreaticcancer AT lvyufeng asevenmirnaexpressionbasedprognosticsignatureanditscorrespondingpotentialcompetingendogenousrnanetworkinearlypancreaticcancer AT heliusheng asevenmirnaexpressionbasedprognosticsignatureanditscorrespondingpotentialcompetingendogenousrnanetworkinearlypancreaticcancer AT baixue sevenmirnaexpressionbasedprognosticsignatureanditscorrespondingpotentialcompetingendogenousrnanetworkinearlypancreaticcancer AT ludonglan sevenmirnaexpressionbasedprognosticsignatureanditscorrespondingpotentialcompetingendogenousrnanetworkinearlypancreaticcancer AT linyan sevenmirnaexpressionbasedprognosticsignatureanditscorrespondingpotentialcompetingendogenousrnanetworkinearlypancreaticcancer AT lvyufeng sevenmirnaexpressionbasedprognosticsignatureanditscorrespondingpotentialcompetingendogenousrnanetworkinearlypancreaticcancer AT heliusheng sevenmirnaexpressionbasedprognosticsignatureanditscorrespondingpotentialcompetingendogenousrnanetworkinearlypancreaticcancer |